USPTO serial 86468629
Serial No. 86468629
Reviewed by CopyMark Law Group
Reg. 4978927Status 710
- Filing date
- Status date
- Registration date
- Jun 14, 2016
- Examiner
- REEVES, APRIL ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 86468629?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robin C. Vance
ROBIN C. VANCE MCGUIREWOODS LLP901 EAST CARY STREETRICHMOND, VA 23219-4030UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Data management, namely, data processing services in the nature of the collection, organization, management, analysis and reporting of data gathered in connection with the conduct of a clinical research trial; biostatistics consulting, namely, consulting related to the collection, summarization, and analysis of statistical information from clinical research trials and the interpretation of, and inference from, the results of such trials for use in the biomedical and pharmaceutical industries for business or commercial purposes; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing the services of project management, namely, business project management in the field of clinical trials; providing the services of site management, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants; business management in the field of clinical trials, namely, monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; business consulting and management in the field of clinical trials, namely, regulatory submission management in the nature of submitting clinical trial protocols to institutional review boards and independent ethics committees on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical trials; providing the services of data management, namely, data compiling, analyzing and tracking in the field of clinical trials for business purposes; providing the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials; logistics management in the field of pharmaceuticals; updating and maintenance of data in computer databases | SECTION 8 - CANCELLED | Jun 30, 2014 |
| 042 | Technical consulting services in the field of conducting clinical trials; providing the services of data management, namely, data compiling, analyzing and tracking in the field of clinical trials for research purposes in the field of medical science and medical consultancy; Pharmaceutical research services, namely, clinical research and development; medical and scientific research, namely, conducting clinical trials, pharmaceutical research services, biotechnology research services, pharmacovigilance in the nature of detection, assessment, and prevention of adverse effects of drugs and other drug-related problems, statistical analysis, and technical writing, all in the field of clinical research; maintenance of online databases for others | SECTION 8 - CANCELLED | Jun 30, 2014 |
| 044 | Medical diagnostic monitoring services | SECTION 8 - CANCELLED | Jun 30, 2014 |
| 045 | Regulatory affairs consulting services, namely, regulatory compliance consulting in the field of pharmaceutical development | SECTION 8 - CANCELLED | Jun 30, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PRA Holdings, Inc.
- Other trademarks owned by PRA Holdings, Inc.
- Other trademarks owned by PRA Holdings, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 23, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Dec 30, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 14, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 14, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 6, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 14, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 13, 2016 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 12, 2016 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 13, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 12, 2016 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 12, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 6, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 8, 2016 | IUAF | USE AMENDMENT FILED | — |
| Mar 8, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 8, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 8, 2016 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 29, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 4, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 29, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 25, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 9, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 10, 2014 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 9, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2014 | NWAP | NEW APPLICATION ENTERED | — |